|
May 15
|
FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing
|
|
May 14
|
Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag
|
|
May 14
|
Novo Nordisk (NVO) Up 3% as Haemophilia Drug Meets Study Goals
|
|
May 14
|
Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
|
|
May 13
|
ANI Pharmaceuticals, Inc. Just Beat EPS By 459%: Here's What Analysts Think Will Happen Next
|
|
May 13
|
ANI Pharmaceuticals Inc (ANIP) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ...
|
|
May 11
|
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q1 2024 Earnings Call Transcript
|
|
May 11
|
ANI Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
|
|
May 10
|
ANI Pharmaceuticals Reports Strong Q1 2024 Results, Surpassing Revenue Expectations
|
|
May 10
|
Nektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates
|
|
May 10
|
Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates
|
|
May 10
|
Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
|
|
May 10
|
Amicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated
|
|
May 10
|
ANI (ANIP) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
May 10
|
Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus
|
|
May 10
|
ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance
|
|
May 9
|
Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues
|
|
May 9
|
Why Earnings Season Could Be Great for ANI Pharmaceuticals (ANIP)
|
|
May 9
|
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
|
|
May 9
|
Acadia (ACAD) Q1 Earnings Surpass Estimates, Revenues Miss
|